About Boule

Boule Diagnostics AB is a rapidly growing diagnostic company that develops, manufactures and sells systems and consumer products for complete blood counts (hematology) to non-institutional healthcare. Sales are carried out through a world wide network of distributors, covering more than 100 countries. The company focuses primarily on small and midsize hospitals, clinics and laboratories in non-institutional healthcare, as well as other diagnostic companies in both human and veterinary hematology. Operations are conducted through commercial subsidiaries in Sweden, the US and China.

The business was founded in 1992 with the acquisition of Karo Bio Diagnostics AB. But the company’s history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell counter. This is an early predecessor of today’s instruments from Boule. The founders of Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., (CDS) has a similar history from Coulter Corporation which developed the world’s first blood cell counter.

Presentations

Company presentation and Q3 report September 8, 2017

Download pdf »


Company presentation and Q2 report August 25, 2017

Download pdf »


Boule Diagnostics AB company presentation 2017-08-17

Download pdf »


Presentation vid Boule Diagnostics AB årsstämma 2017

Download (Swedish) pdf »


Presentation vid Boule Diagnostics AB årsstämma 2016

Download (Swedish) pdf »


Boule Diagnostics AB bolagspresentation – Aktiespararnas Aktiedagen 2015-03-09

Download (Swedish) pdf »


Boule Diagnostics AB företagspresentation – LifeScience/Healthcare-dagen 2014-03-05

Download (Swedish) pdf »


Boule Diagnostics AB bolagspresentation 2013-04-23

Download (Swedish) pdf »